Surface engineered metal-organic frameworks as active targeting nanomedicines for mono- and multi-therapy-Reference-Cited by-同舟云学术

Surface engineered metal-organic frameworks as active targeting nanomedicines for mono- and multi-therapy

Published:2022-12 Issue: Volume:29 Page:101646
ISSN:2352-9407
Container-title:Applied Materials Today
language:en
Short-container-title:Applied Materials Today

Author:

Masoudifar Reyhane,Pouyanfar Niki^ORCID,Liu Dongfei,Ahmadi Mahnaz,Landi Behnaz,Akbari Mahsa^ORCID,Moayeri-Jolandan Sina,Ghorbani-Bidkorpeh Fatemeh,Asadian Elham,Shahbazi Mohammad-Ali^ORCID

Funder

Zanjan University of Medical Sciences

Rijksuniversiteit Groningen

Publisher

Elsevier BV

Subject

General Materials Science

Reference205 articles.

1. Cancer nanomedicine: a review of recent success in drug delivery;Tran;Clin. Transl. Med.,2017

2. Nano based drug delivery systems: recent developments and future prospects;Patra;J. Nanobiotechnol.,2018

3. Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview;Farooq;Artif. Cells Nanomed. Biotechnol.,2019

4. Passive and active drug targeting: drug delivery to tumors as an example;Torchilin;Drug Deliv.,2010

5. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites;Attia;J. Pharm. Pharmacol.,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal organic framework modulated nanozymes tailored with their biomedical approaches;CHINESE CHEM LETT;2024

2. The utilization of metal-organic frameworks in tumor-targeted drug delivery systems;Journal of Science: Advanced Materials and Devices;2024-09

3. Nanoparticle-integrated metal–organic frameworks: a revolution in next-generation drug delivery systems;Journal of Pharmaceutical Investigation;2024-08-02

4. Engineering peptide drug therapeutics through chemical conjugation and implication in clinics;Medicinal Research Reviews;2024-05-05

5. Metal–Organic Frameworks for Cisplatin Delivery to Cancer Cells: A Molecular Dynamics Simulation;ACS Omega;2024-04-22